In its Q2 2026 investor letter, Meridian Small Cap Growth Fund highlighted Tandem Diabetes Care, Inc. (NASDAQ:TNDM).
Headquartered in San Diego, California, Tandem Diabetes Care, Inc. (NASDAQ:TNDM) is a medical device company that offers technology solutions for people living with diabetes
On July 29, 2026, Tandem Diabetes Care, Inc. (NASDAQ:TNDM) closed at $18.59 per share, reflecting a market capitalization of $1.27 billion. Tandem Diabetes Care, Inc. (NASDAQ:TNDM) posted a one-month return of 21.34%, while its shares gained 19.32% over the past 52 weeks. Meridian Small Cap Growth Fund stated the following regarding Tandem Diabetes Care, Inc. (NASDAQ:TNDM) in its Q2 2026 investor update: “Tandem Diabetes Care, Inc. (NASDAQ:TNDM) is a medical device company focused on insulin delivery, best known for its t:slim X2 and Mobi automated insulin pumps.
We own it for its differentiated pump technology, growing installed base, and the recurring supply revenue that expands with its user base. Shares declined during the quarter as the company’s transition to a pharmacy-based, pay-as-you-go reimbursement model clouded near-term revenue visibility, and second-quarter guidance came in below expectations even as the underlying quarter was broadly in line. Heightened attention to a new competing patch-pump entrant added to the caution, and the name’s lower-beta profile lagged in a market that favored higher-beta and non-earning stocks; we continue to believe the reimbursement transition is a long-term positive.”